Medtermrcm Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 50.00 K
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.58 Cr
- Revenue Growth 68.38%
- Profit Growth -48.26%
- Ebitda -24.55%
- Net Worth 51.60%
- Total Assets 143.91%
About Medtermrcm
Medtermrcm Private Limited (MPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 April 2021 (Three years and nine months 10 days old ). Its registered office is in Ganganagar, Rajasthan, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹5.58 Cr.
Anil Bhamboo and Kamla Devi serve as directors at the Company.
Company Details
-
Location
Ganganagar, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999RJ2021PTC074735
-
Company No.
074735
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Apr 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Medtermrcm?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Bhamboo
|
Director | 16-Aug-2022 | Current |
|
Kamla Devi
|
Director | 16-Aug-2022 | Current |
Financial Performance of Medtermrcm.
Medtermrcm Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.38% increase. The company also saw a substantial fall in profitability, with a 48.26% decrease in profit. The company's net worth Soared by an impressive increase of 51.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medtermrcm?
Unlock access to Medtermrcm's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹55.80 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.50 Cr
- Hdfc Bank Limited : 1.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2023 | Others | ₹4.50 Cr | Open |
| 04 Apr 2023 | Hdfc Bank Limited | ₹5.40 M | Open |
| 03 Mar 2023 | Hdfc Bank Limited | ₹5.40 M | Open |
How Many Employees Work at Medtermrcm?
Medtermrcm has a workforce of 324 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medtermrcm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medtermrcm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
